/NMRD

NMRD Stock - Nemaura Medical Inc.

Q: What is the analyst price target for NMRD?

Analyst price target information is not currently available for NMRD.

Q: What is NMRD's market cap?

Market capitalization information is not currently available for NMRD.

Healthcare|Medical - Devices|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for NMRD

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.92

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$77,044	$503,906	N/A	N/A	N/A
Gross Profit	$-1,476,392	$159,606	$-98,075	N/A	N/A
Gross Margin	-1916.3%	31.7%	N/A	N/A	N/A
Operating Income	$-9,595,234	$-7,570,431	$-4,586,741	$-4,778,484	$-4,476,724
Net Income	$-14,143,735	$-13,886,805	$-6,258,596	$-4,160,196	$-4,452,797
Net Margin	-18358.0%	-2755.8%	N/A	N/A	N/A
EPS	$-0.57	$-0.59	$-0.28	$-0.20	$-0.25

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Visit Website

Earnings History & Surprises

NMRD

Beat Rate

20%

Last 10 quarters

Avg Surprise

-5.0%

EPS vs Estimate

Beats / Misses

2/6

2 met exactly

Latest EPS

$-0.12

Q1 2024

EPS Surprise History

Q2 22

0.0%

$-0.15vs$-0.15

Q3 22

-6.3%

$-0.17vs$-0.16

Q1 23

No data

Q1 23

+61.1%

$-0.07vs$-0.18

Q3 23

-12.5%

$-0.18vs$-0.16

Q3 23

+35.7%

$-0.09vs$-0.14

Q4 23

-10.0%

$-0.11vs$-0.10

Q1 24

0.0%

$-0.12vs$-0.12

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2025	Sep 29, 2025	—	—	—	—
Q2 2025	Jun 30, 2025	—	—	—	—
Q2 2025	May 30, 2025	—	—	—	—
Q1 2025	Feb 25, 2025	—	—	—	—
Q4 2024	Nov 19, 2024	—	—	—	—
Q3 2024	Aug 26, 2024	—	—	—	—
Q3 2024	Aug 26, 2024	—	—	—	—
Q1 2024	Feb 12, 2024	$-0.12	$-0.12	0.0%	= MET
Q4 2023	Nov 13, 2023	$-0.10	$-0.11	-10.0%	✗ MISS
Q3 2023	Aug 14, 2023	$-0.14	$-0.09	+35.7%	✓ BEAT
Q3 2023	Jul 13, 2023	$-0.16	$-0.18	-12.5%	✗ MISS
Q1 2023	Feb 24, 2023	$-0.18	$-0.07	+61.1%	✓ BEAT
Q1 2023	Feb 24, 2023	—	$-0.16	—	—
Q3 2022	Aug 15, 2022	$-0.16	$-0.17	-6.3%	✗ MISS
Q2 2022	Jun 30, 2022	$-0.15	$-0.15	0.0%	= MET
Q1 2022	Feb 11, 2022	$-0.14	$-0.15	-7.1%	✗ MISS
Q4 2021	Nov 15, 2021	$-0.11	$-0.15	-36.4%	✗ MISS
Q3 2021	Aug 16, 2021	$-0.08	$-0.14	-75.0%	✗ MISS
Q2 2021	Jun 29, 2021	—	$-0.09	—	—
Q1 2021	Feb 16, 2021	—	$-0.06	—	—

Frequently Asked Questions about NMRD

What is NMRD's current stock price?

Nemaura Medical Inc. (NMRD) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for NMRD?

No analyst price targets are currently available for this stock.

What sector is Nemaura Medical Inc. in?

Nemaura Medical Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is NMRD's market cap?

Nemaura Medical Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does NMRD pay dividends?

No, Nemaura Medical Inc. does not currently pay a dividend to shareholders.